Poster 279 One Year Follow-up of Relationships of Body Mass Index With Impairments, Functional Limitations, and Disability in Subject Who Were Obese

PM&R ◽  
2011 ◽  
Vol 3 ◽  
pp. S268-S268
Author(s):  
Monique B. Perry ◽  
Naomi Lynn H. Gerber ◽  
Ching-yi A. Shieh ◽  
Monica C. Skarulis
Keyword(s):  
Body Mass Index ◽  
Body Mass ◽  
Functional Limitations ◽  
One Year

scholarly journals Challenging the “jolly fat” hypothesis among older adults: High body mass index predicts increases in depressive symptoms over a 5-year period

2016 ◽  
Vol 23 (1) ◽  
pp. 48-58 ◽  
Author(s):  
Peter Joseph Dearborn ◽  
Michael A Robbins ◽  
Merrill F Elias
Keyword(s):  
Older Adults ◽  
Body Mass Index ◽  
Depressive Symptoms ◽  
Body Mass ◽  
Functional Limitations ◽  
High Body Mass Index ◽  
Obesity Prevalence ◽  
Community Based ◽  
Objectively Measured

Several investigators have observed lowered risk of depression among obese older adults, coining the “jolly fat” hypothesis. We examined this hypothesis using baseline and a 5-year follow-up body mass index, depressive symptoms, and covariates from 638 community-based older adults. High objectively measured body mass index and functional limitations predicted increased future depressive symptoms. However, symptoms did not predict future body mass index. Self-reported body mass index showed similar associations despite underestimating obesity prevalence. Results did not differ on the basis of gender. Results for this study, the first longitudinal reciprocal risk analysis between objectively measured body mass index and depressive symptoms among older adults, do not support the “jolly fat” hypothesis.

Catha Edulis (Khat) Chewing Decreases Serum Levels of Iron, Ferritin and Vitamin B12 and Increases Folic Acid

2014 ◽  
Vol 84 (5-6) ◽  
pp. 223-228
Author(s):  
Waled Al-Dubai ◽  
Jameel Al-Ghazaly ◽  
Molham Al-Habori ◽  
Riyadh Saif-Ali ◽  
Ahmed Mohammed
Keyword(s):  
Body Mass Index ◽  
Folic Acid ◽  
Body Mass ◽  
Serum Iron ◽  
Serum Levels ◽  
Control Group ◽  
Vitamin B ◽  
Catha Edulis ◽  
One Year

Abstract. Background: Catha edulis (Khat) is customarily chewed to attain a state of stimulation and reduce physical fatigue. In view of the reported common adverse effects of Khat, the aim of this study was to evaluate the levels of iron, ferritin, folic acid, vitamin B12 and body mass index (BMI) as nutritive indicators in Yemeni Khat chewers. Methods: This study was a prospective cohort study, carried out on 90 male workers aged 19 - 23 years old; 45 were healthy non-Khat chewers serving as control group and 45 were regular Khat chewers. Serum iron, ferritin, folic acid, vitamin B12 and body mass index were measured at baseline and after a year of follow up. Results: Serum iron and BMI were significantly (p < 0.01) lower at baseline in Khat chewers by 9 % and 6 %, respectively; whereas ferritin, folic acid and vitamin B12 were non-significantly different from non-Khat chewers. In the follow-up one year later, serum iron, ferritin, vitamin B12 and BMI were significantly (p < 0.001) lower in Khat chewers by 19.0, 31.4, 20.6 and 10.7 %; whereas folic acid was significantly (p = 0.007) higher by 26.7 %. Comparison within groups showed serum iron, ferritin, and BMI to be significantly (p < 0.01) decreased after one year in the Khat chewers with respect to its baseline; whereas folic acid significantly (p < 0.001) increased. Conclusion: This study shows Khat chewers to be more susceptible to malnutrition, which should be considered by the general population and the public health authorities.

Vitamin D status and body mass index in older Finnish people: A one-year follow-up study

2015 ◽  
Vol 6 (2) ◽  
pp. 163-164
Author(s):  
Marika Salminen ◽  
Maritta Salonoja ◽  
Sari Vaapio ◽  
Tero Vahlberg ◽  
Christel Lamberg-Allardt ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Vitamin D ◽  
Body Mass ◽  
Vitamin D Status ◽  
Follow Up Study ◽  
One Year

Abstract P003: Effectiveness And Safety Of Direct Oral Anticoagulants Compared With Warfarin In Patients With Atrial Fibrillation Across Body Mass Index Categories

Circulation ◽  
2021 ◽  
Vol 143 (Suppl_1) ◽  
Author(s):  
Yoshihiro Tanaka ◽  
Sadiya Khan ◽  
Rachel Kaplan ◽  
Philip Greenland ◽  
Rod S Passman ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Body Mass Index ◽  
Body Mass ◽  
Intracranial Hemorrhage ◽  
Propensity Scores ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Safety Outcome ◽  
One Year

Background: Although direct oral anticoagulants (DOACs) are preferred for most patients needing anticoagulation for atrial fibrillation (AF), uncertainty remains in the effectiveness and safety of DOACs compared with warfarin in patients with obesity. Available data from large real-word cohorts are lacking. Purpose: To examine the effectiveness and safety of DOACs compared with warfarin in patients with obesity and AF. Methods: We conducted a retrospective cohort study at an integrated, multi-site healthcare system. We included patients with AF prescribed either a DOAC or warfarin with ≥ one year of follow-up between 2010-2017. The primary effectiveness outcome was ischemic stroke or systemic embolism (S/SE) and the primary safety outcome was incident intracranial hemorrhage (ICH). Using logistic regression, we calculated propensity scores (PS) of prescription for DOAC in each body mass index (BMI) category (<25 kg/m2, 25.0-29.9 kg/m2, 30.0 to 34.9 kg/m2, and BMI≥35.0 kg/m2) using the following covariates: age, sex, race, ethnicity, BMI, systolic blood pressure, and CHA 2 DS 2 -VASc score. We used inverse probability weighting (IPW) based on the PS and IPW-weighted hazard ratios with 95% confidence intervals were calculated by Cox proportional hazard model. Results: Of a total of 17,905 patients included, mean (standard deviation [SD]) age was 70 ± 12 years and mean (SD) BMI was 29.9 ± 6.7 kg/m 2 ; nearly half received a prescription for DOAC (42.7%) and 57.3% for warfarin. During median follow-up of 3.8 years (interquartile range: 2.2-6.0), a total of 159 stroke and 376 intracranial hemorrhage events were observed. Patients on DOACs had a similar or lower HRs for both S/SE and ICH events compared with warfarin across each BMI category (Figure). Conclusion: In this retrospective study, DOACs were as safe and effective compared with warfarin across BMI categories in patients with AF.

Body Mass Index Following Traumatic Brain Injury: Demographic and Psychosocial Variables at Injury and One-Year Follow-up

2015 ◽  
Vol 96 (10) ◽  
pp. e59
Author(s):  
Amanda Childs ◽  
Coralynn Long ◽  
Michelle Smith ◽  
Valerie Ellois ◽  
Lucia Smith-Wexler ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Body Mass ◽  
Psychosocial Variables ◽  
One Year

scholarly journals Longitudinal Changes in Obesity and Body Mass Index Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study

2008 ◽  
Vol 26 (28) ◽  
pp. 4639-4645 ◽  
Author(s):  
Edward G. Garmey ◽  
Qi Liu ◽  
Charles A. Sklar ◽  
Lillian R. Meacham ◽  
Ann C. Mertens ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Acute Lymphoblastic Leukemia ◽  
Childhood Cancer ◽  
Body Mass ◽  
Cancer Survivor ◽  
Comparison Group ◽  
Lymphoblastic Leukemia ◽  
Childhood Cancer Survivor ◽  
Childhood Cancer Survivor Study

Purpose We examined the rate of increase in the body mass index (BMI; kg/m2) after final height attainment in survivors of acute lymphoblastic leukemia (ALL) and a noncancer comparison group. Methods Childhood Cancer Survivor Study (CCSS) is a retrospectively ascertained cohort study that prospectively tracks the health status of adults who were diagnosed with childhood cancer between 1970 and 1986 and a comparison group of siblings. Changes in BMI from baseline enrollment to time of completion of follow-up (mean interval, 7.8 years) were calculated for 1,451 ALL survivors (mean age, 32.3 years at follow-up) and 2,167 siblings of childhood cancer survivors (mean age, 35.9 years). Results The mean BMI of the CCSS sibling comparison group increased with age (women, 0.25 units/yr, 95% CI, 0.22 to 0.28 units; men, 0.23 units/yr, 95% CI, 0.20 to 0.25 units). Compared with CCSS siblings, ALL survivors who were treated with cranial radiation therapy (CRT) had a significantly greater increase in BMI (women, 0.41 units/yr, 95% CI, 0.37 to 0.45 units; men, 0.29 units/yr; 95% CI, 0.26 to 0.32 units). The rate of BMI increase was not significantly increased for ALL survivors who were treated with chemotherapy alone. Younger age at CRT exposure significantly modified risk. Conclusion CRT used in the treatment of childhood ALL is associated with a greater rate of increasing BMI, particularly among women treated with CRT during the first decade of life. Health care professionals should be aware of this risk and interventions to reduce or manage weight gain are essential in this high-risk population.

Sign in / Sign up

Export Citation Format

Share Document